Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 08:46 am Purchase | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 7,000,000 8.64% | 2,300,000 (+48.94%) | View |
| 2023-02-14 08:40 am Purchase | 13G | Quanterix Corporation QTRX | Camber Capital Management LP | 3,425,000 9.24% | 425,000 (+14.17%) | View |
| 2023-02-14 08:36 am Purchase | 13G | ZimVie Inc. ZIMV | Camber Capital Management LP | 2,600,000 9.97% | 600,000 (+30.00%) | View |
| 2023-02-14 08:33 am Purchase | 13G | Brookdale Senior Living Inc. BKD | Camber Capital Management LP | 18,000,000 9.64% | 2,000,000 (+12.50%) | View |
| 2023-02-14 08:30 am Purchase | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 4,235,000 9.28% | 2,185,000 (+106.59%) | View |
| 2023-02-02 2:53 pm Unchanged | 13G | OraSure Technologies, Inc. OSUR | Camber Capital Management LP | 4,250,000 5.85% | 0 (Unchanged) | View |
| 2022-12-12 09:50 am Purchase | 13G | Solid Biosciences Inc. SLDB | Camber Capital Management LP | 1,418,440 7.26% | 1,418,440 (New Position) | View |
| 2022-08-19 4:02 pm Purchase | 13G | Quanterix Corporation QTRX | Camber Capital Management LP | 3,000,000 8.11% | 3,000,000 (New Position) | View |
| 2022-05-12 4:06 pm Purchase | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 4,700,000 5.85% | 1,950,000 (+70.91%) | View |
| 2022-03-21 09:11 am Purchase | 13G | ZimVie Inc. ZIMV | Camber Capital Management LP | 2,000,000 7.68% | 2,000,000 (New Position) | View |
| 2022-02-14 09:40 am Sale | 13G | Collegium Pharmaceutical, Inc. COLL | Camber Capital Management LP | 1,050,000 3.04% | -950,000 (-47.50%) | View |
| 2022-02-14 09:39 am Sale | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 2,750,000 3.44% | -2,250,000 (-45.00%) | View |
| 2022-02-14 09:36 am Sale | 13G | AVROBIO, Inc. AVRO | Camber Capital Management LP | 1,633,333 3.74% | -1,500,000 (-47.87%) | View |
| 2022-02-14 09:35 am Sale | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 2,050,000 5.01% | -505,000 (-19.77%) | View |
| 2022-02-14 09:34 am Purchase | 13G | Brookdale Senior Living Inc. BKD | Camber Capital Management LP | 16,000,000 8.63% | 3,800,000 (+31.15%) | View |
| 2021-11-08 08:05 am Unchanged | 13D | OraSure Technologies, Inc. OSUR | Camber Capital Management LP | 4,250,000 5.9% | 0 (Unchanged) | View |
| 2021-07-29 09:20 am Purchase | 13G | OraSure Technologies, Inc. OSUR | Camber Capital Management LP | 4,250,000 5.91% | 4,250,000 (New Position) | View |
| 2021-02-16 08:27 am Sale | 13G | AMAG PHARMACEUTICALS INC. AMAG | Camber Capital Management LP | 0 0% | -4,390,000 (Position Closed) | View |
| 2021-02-16 08:25 am Sale | 13G | Brookdale Senior Living Inc. BKD | Camber Capital Management LP | 12,200,000 6.65% | -300,000 (-2.40%) | View |
| 2021-02-16 08:24 am Sale | 13G | GlycoMimetics, Inc. GLYC | Camber Capital Management LP | 2,200,000 4.6% | -1,300,000 (-37.14%) | View |